Anti‐VEGF vs control
Reduction in central retinal thickness at one year · people with neovascular age‐related macular degeneration
The review found no eligible studies for this question.
1 finding from 1 review
- Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found